Oldies still ACE the management of advanced CKD!
RASi in advanced CKD - The Visual Abstract
Does initiation of ACEi and ARB help in advanced CKD? Check out the VA by Dr Nikhil John
This week, NephJC will discuss whether obinutuzumab is ready to outperform tacrolimus in primary membranous nephropathy
In this edition of NephJC, we discuss the largest case series of kidney biopsies in patients with Diabetes.
This week we will discuss whether a bundled, team-based hypertension intervention- featuring intensive BP targets, home monitoring, health coaching, and audit feedback- can overcome poverty, clinical inertia, and fragmented care to improve blood pressure control in low-income patients receiving care at federally qualified health centers.
This week, we will discuss a phase 2 trial of the TRPC6 inhibitor BI 764198 in FSGS—an early signal for a podocyte-targeted therapy showing proteinuria reduction but set against small numbers, heterogeneity, and methodological trade-offs that frame this as direction-finding rather than definitive evidence.
systematic review and meta-analysis
Oldies still ACE the management of advanced CKD!
Does initiation of ACEi and ARB help in advanced CKD? Check out the VA by Dr Nikhil John